lead has been researched along with Dermatitis Medicamentosa in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shannon, MW; Townsend, MK | 1 |
| Morgan, JM | 1 |
2 trial(s) available for lead and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Adverse effects of reduced-dose d-penicillamine in children with mild-to-moderate lead poisoning.
Topics: Adolescent; Blood Cell Count; Chelating Agents; Child; Child, Preschool; Drug Eruptions; Female; Humans; Infant; Lead; Lead Poisoning; Leukopenia; Male; Penicillamine; Retrospective Studies; Thrombocytopenia | 2000 |
Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 microg/dL. Treatment of Lead-Exposed Children (TLC) Trial Group.
Topics: Chelating Agents; Child, Preschool; Drug Eruptions; Humans; Infant; Lead; Lead Poisoning, Nervous System, Childhood; Safety; Scalp; Succimer; Wounds and Injuries | 2000 |
1 other study(ies) available for lead and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Chelation therapy in lead nephropathy.
Topics: Acute Kidney Injury; Administration, Oral; Chelating Agents; Creatinine; Dimercaprol; Drug Eruptions; Drug Therapy, Combination; Edetic Acid; Humans; Hypocalcemia; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Kidney Diseases; Lead; Lead Poisoning; Male; Penicillamine; Thrombophlebitis | 1975 |